Company: DK
Filing Date: 2025-03-20
Form Type: DEF 14A
Source: 0001140361-25-009658
Chunk: 0

Company: Delek US Holdings, Inc.
Filing Date: 2025-03-20
Form: DEF 14A
Chunk 0
---
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.14a-12 Delek US Holdings, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act rules 14a6(i)(1) and 0-11

TABLE OF CONTENTS

NOTICE OF THE 2025 ANNUAL MEETING OF STOCKHOLDERS To Our Stockholders:

Notice is hereby given that the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Delek US Holdings, Inc. (the “Company,” “Delek,” “we,” “us,” or “our”) will be held on April 29, 2025 at 11:30 a.m., central time, for the following purposes: Items of Business:

| (1) | To elect ten directors of the Company to serve until the 2026 Annual Meeting of Stockholders or until their respective successors are appointed, elected and qualified; |

| (2) | To adopt the advisory resolution approving the Company’s executive compensation program for our named executive officers as described in the Proxy Statement; |

| (3) | To approve an amendment to our 2016 Long-Term Incentive Plan to increase the number of shares available for issuance thereunder; |

| (4) | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year; and |

| (5) | To transact any other business properly brought before the Annual Meeting. |

We will once again conduct our